Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems

Dissertation (MSc (Biochemistry))--University of Pretoria, 2020.

Saved in:
Bibliographic Details
Other Authors: Birkholtz, Lyn-Marie
Format: Thesis
Language:English
Published: University of Pretoria 2021
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613453717340160
access_status_str Open Access
author2 Birkholtz, Lyn-Marie
author_browse Birkholtz, Lyn-Marie
author_facet Birkholtz, Lyn-Marie
collection Thesis
dc_rights_str_mv © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc (Biochemistry))--University of Pretoria, 2020.
format Thesis
id oai:repository.up.ac.za:2263/78127
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:36:23.737Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/78127 Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems Birkholtz, Lyn-Marie u13062922@tuks.co.za Coertzen, Dina Leshabane, Meta Kgaogelo UCTD biochemistry malaria nanoparticles Plasmodium falciparum drug delivery drug discovery Dissertation (MSc (Biochemistry))--University of Pretoria, 2020. The multistage life cycle of malaria-causing P. falciparum is complex, making prevention and treatment difficult. As a result of resistance to many antimalarial drugs, novel compounds with unexplored targets are constantly sought after for the purpose of treating the symptoms of malaria. Here, novel compounds were screened for antiplasmodial activity against the symptom-causing asexual intraerythrocytic malaria-causing parasites. Unfortunately, many novel compounds in the drug discovery pipeline and drugs in clinical use possess underlying pharmacological issues that makes administration challenging. These include low aqueous solubility and short half-life which negatively impact bioavailability resulting in toxicity. This, in turn, increases patient non-compliance and the emergence of drug-resistant strains. Nanoparticles (NP) have the ability to mask drugs from the external environment while increasing circulation time and often alleviate many issues at once. Furthermore, the selected drugs do not need to be modified. Drug conjugation NPs with a targeting ligand and stimuli-responsive linkers have been extensively researched in many diseases, however, none have been reported for malaria clinically. Here, the first acid-labile targeted NP (tNP) that exploits the biology of infected erythrocytes and the specialised food vacuole (FV) of P. falciparum is interrogated for ability to decrease toxicity while retaining antimalarial activity. This dissertation describes the effect of tNPs on the efficacy and toxicity of selected compounds. In vitro haemolysis and cytotoxicity assays revealed that the tNPs are biocompatible to erythrocytes and HepG2 cells. The data also shows that tNPs decrease the toxicity of drugs and the chosen novel compound against human cells. A decrease in antiplasmodial activity was observed in vitro for the tNPs when compared to the novel compound and drugs on their own. However, this was due to the biogenesis of the FV and a shortened window of release. Nonetheless, the NP backbone was not active against P. falciparum intraerythrocytic parasites whereas tNPs were, showing activity due to released drug. The targeting ligand was also not specific for antiplasmodial activity. Although a significant loss in activity is observed, the results presented here suggests that these novel acid-labile tNPs serve as an attractive starting point for targeted treatment of malaria with an improved patient tolerance. Furthermore, novel compounds with issues can be selected without having to be modified or completely discarded. Therefore, increasing the chances of finding a variety of compounds that can be used to treat malaria while keeping patients safe. NRF Biochemistry MSc (Biochemistry) Unrestricted 2021-01-26T09:11:52Z 2021-01-26T09:11:52Z 2021 2020 Dissertation Leshabane, MK 2020, Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems, MSc dissertation, University of Pretoria, Pretoria, viewed yymmdd http://hdl.handle.net/2263/78127 A2021 http://hdl.handle.net/2263/78127 en © 2019 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle UCTD
biochemistry
malaria
nanoparticles
Plasmodium falciparum
drug delivery
drug discovery
Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title_full Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title_fullStr Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title_full_unstemmed Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title_short Novel acid-labile and targeted nanoparticles as possible antimalarial drug delivery systems
title_sort novel acid labile and targeted nanoparticles as possible antimalarial drug delivery systems
topic UCTD
biochemistry
malaria
nanoparticles
Plasmodium falciparum
drug delivery
drug discovery
url http://hdl.handle.net/2263/78127